The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells
Abstract
Somatic cell nuclear transfer allows trans-acting factors present in the mammalian oocyte to reprogram somatic cell nuclei to an undifferentiated state. We show that four factors ( OCT4, SOX2, NANOG , and LIN28 ) are sufficient to reprogram human somatic cells to pluripotent stem cells that exhibit the essential characteristics of embryonic stem (ES) cells. These induced pluripotent human stem cells have normal karyotypes, express telomerase activity, express cell surface markers and genes that characterize human ES cells, and maintain the developmental potential to differentiate into advanced derivatives of all three primary germ layers. Such induced pluripotent human cell lines should be useful in the production of new disease models and in drug development, as well as for applications in transplantation medicine, once technical limitations (for example, mutation through viral integration) are eliminated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Retro/lentiviruses have enabled genetic approaches in cultured primary cells to ectopically express genes of interest (1–6).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Viral screens using focused overexpression libraries can identify putative reprogramming factors, for example, by identifying a defined set of transcription factors that are selectively required to induce pluripotent stem cells (2–4,7) or trans-differentiate from mature somatic cell into another mature somatic cell (1,8–11).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Despite the power of viral technologies, pooled screens for cell reprogramming have generally adopted a one-by-one elimination approach or testing for exhaustive combinations and interrogating phenotypes in cell culture from transgenic mice (1,3,10) and/or aberrantly cloned cell lines (12).”
From Establishment of single-cell screening system for the rapid identification of transcriptional modulators involved in direct cell reprogramming (2012) · cites this paper as [3]
In the citing paper
“Successful transformation of human somatic cells into iPSCs was first carried out in 2007 using a lentiviral system [95].”
From Non-Integrating Lentiviral Vectors in Clinical Applications: A Glance Through (2022) · cites this paper as [95]
In the citing paper
“It has been shown that NANOG and LIN28 in combination with SOX2 and OCT4 can reprogram human somatic cells into iPS cells 30 by increasing reprogramming efficiency by 76-fold 60 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [30]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Self-citationThe ENCODE Project Consortium (2007) · Nature · doi:10.1038/nature05874 · Cited by 5,223
Viable offspring derived from fetal and adult mammalian cells
Wilmut, I., Schnieke, A. E., McWhir, J., Kind, A. J., & Campbell, K. H. S. (1997) · Nature · doi:10.1038/385810a0 · Cited by 4,969
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., Bernstein, B. E., & Jaenisch, R. (2007) · Nature · doi:10.1038/nature05944 · Cited by 2,676
Maherali, N., Sridharan, R., Xie, W., Utikal, J., Eminli, S., Arnold, K., Stadtfeld, M., Yachechko, R., Tchieu, J., Jaenisch, R., et al. (2007) · Cell stem cell · doi:10.1016/j.stem.2007.05.014 · Cited by 1,725
Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells
Meissner, A., Wernig, M., & Jaenisch, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1335 · Cited by 763
Homologous recombination in human embryonic stem cells
Zwaka, T. P., & Thomson, J. A. (2003) · Nature Biotechnology · doi:10.1038/nbt788 · Cited by 666
Self-citationVodyanik, M. A., Bork, J. A., Thomson, J. A., & Slukvin, I. I. (2005) · Blood · doi:10.1182/blood-2004-04-1649 · Cited by 619
Self-citation
Cited by
Items 101–200 of 1,132
Lin28 promotes transformation and is associated with advanced human malignancies
Viswanathan, S. R., Powers, J. T., Einhorn, W., Hoshida, Y., Ng, T. L., Toffanin, S., O'Sullivan, M., Lu, J., Phillips, L. A., Lockhart, V. L., et al. (2009) · Nature Genetics · doi:10.1038/ng.392 · Cited by 814
“Recently, LIN28 was used together with OCT4, NANOG and SOX2 to reprogram human somatic fibroblasts to pluripotenc”
MethodDirect Reprogramming of Terminally Differentiated Mature B Lymphocytes to Pluripotency
Hanna, J., Markoulaki, S., Schorderet, P., Carey, B. W., Beard, C., Wernig, M., Creyghton, M. P., Steine, E. J., Cassady, J. P., Foreman, R., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.028 · Cited by 814
“Finally, it has been also shown that human iPS cells can be generated by transduction of defined factors into fibroblasts (Park et al., 2008; Takahashi et al., 2007; Yu et al., 2007).”
Schiebinger, G., Shu, J., Tabaka, M., Cleary, B., Subramanian, V., Solomon, A., Gould, J., Liu, S., Lin, S., Berube, P., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.006 · Cited by 829
Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse
Stadtfeld, M., Maherali, N., Breault, D. T., & Hochedlinger, K. (2008) · Cell stem cell · doi:10.1016/j.stem.2008.02.001 · Cited by 823
“…into oocytes (Wakayama et al., 1998; Wilmut et al., 1997), by cell fusion between ES cells and somatic cells (Cowan et al., 2005; Tada et al., 2003), and by the ectopic expression of transcription factors in somatic cells (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007).”
BackgroundMethodInfluentialScaffolds and cells for tissue regeneration: different scaffold pore sizes—different cell effects
Bružauskaitė, I., Bironaitė, D., Bagdonas, E., & Bernotienė, E. (2016) · Cytotechnology · doi:10.1007/s10616-015-9895-4 · Cited by 797
“Recently many other reprogramming strategies based on genes, proteins, iRNR and different chemicals are also available for the reprogramming of somatic cells (Yu et al. 2007; Nakagawa et al. 2008).”
BackgroundNuclear reprogramming to a pluripotent state by three approaches
Yamanaka, S., & Blau, H. M. (2010) · Nature · doi:10.1038/nature09229 · Cited by 776
“or different, but overlapping, cocktails of factor”
Rybak, A., Fuchs, H., Smirnova, L., Brandt, C., Pohl, E. E., Nitsch, R., & Wulczyn, F. G. (2008) · Nature Cell Biology · doi:10.1038/ncb1759 · Cited by 787
“lin-28 is one of four genes that cooperate to induce pluripotency when ectopically expressed in somatic cell”
BackgroundA Small-Molecule Inhibitor of Tgf-β Signaling Replaces Sox2 in Reprogramming by Inducing Nanog
Ichida, J. K., Blanchard, J., Lam, K., Son, E. Y., Chung, J. E., Egli, D., Loh, K. M., Carter, A. C., Di Giorgio, F. P., Koszka, K., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.09.012 · Cited by 808
“, 2003) and has been shown to enhance the efficiency of reprogramming (Silva et al., 2006; Silva et al., 2009; Yu et al., 2007), we decided to test whether Nanog could directly replace Sox2 in reprogramming.”
BackgroundiPS cells produce viable mice through tetraploid complementation
Zhao, X.-Y., Li, W., Lv, Z., Liu, L., Tong, M., Hai, T., Hao, J., Guo, C.-L., Ma, Q.-W., Wang, L., et al. (2009) · Nature · doi:10.1038/nature08267 · Cited by 777
Distinct epigenomic landscapes of pluripotent and lineage-committed human cells
Hawkins, R. D., Hon, G. C., Lee, L. K., Ngo, Q., Lister, R., Pelizzola, M., Edsall, L. E., Kuan, S., Luu, Y., Klugman, S., et al. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.03.018 · Cited by 806
“For example, the OCT4/SOX2/NANOG network enables self-renewal properties of ESCs, and ectopic expression of these factors together with additional transcription factors reprogram somatic cells into pluripotent cells (iPSCs) (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007).”
BackgroundSelf-citationPathological Ventricular Remodeling: Mechanisms: Part 1 of 2
Burchfield, J. S., Xie, M., & Hill, J. A. (2013) · Circulation · doi:10.1161/circulationaha.113.001878 · Cited by 766
Human Embryonic Stem Cells Derived by Somatic Cell Nuclear Transfer
Tachibana, M., Amato, P., Sparman, M., Gutierrez, N. M., Tippner-Hedges, R., Ma, H., Kang, E., Fulati, A., Lee, H.-S., Sritanaudomchai, H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.05.006 · Cited by 769
“An approach to patient-specific pluripotent stem cell derivation that precludes the use of embryos is based on somatic cell reprogramming by induced expression of a few critical transcription factors (referred as induced pluripotent stem cells [iPSCs]) (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al.,…”
BackgroundDerivation of blood-brain barrier endothelial cells from human pluripotent stem cells
Lippmann, E. S., Azarin, S. M., Kay, J. E., Nessler, R. A., Wilson, H. K., Al-Ahmad, A., Palecek, S. P., & Shusta, E. V. (2012) · Nature Biotechnology · doi:10.1038/nbt.2247 · Cited by 800
Wang, Y., Xu, Z., Jiang, J., Xu, C., Kang, J., Xiao, L., Wu, M., Xiong, J., Guo, X., & Liu, H. (2013) · Developmental Cell · doi:10.1016/j.devcel.2013.03.002 · Cited by 781
Ma, J., Guo, L., Fiene, S. J., Anson, B. D., Thomson, J. A., Kamp, T. J., Kolaja, K. L., Swanson, B. J., & January, C. T. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00694.2011 · Cited by 770
“The hiPSC cell line was created by reprogramming a human fibroblast cell line by retroviral expression of the reprogramming factors sox7, oct4, nanog, and lin28 similar to Yu and colleagues (50) using Moloney murine leukemia virus viral constructs (50).”
MethodSelf-citationPioneer Transcription Factors Target Partial DNA Motifs on Nucleosomes to Initiate Reprogramming
Soufi, A., Garcia, M. F., Jaroszewicz, A., Osman, N., Pellegrini, M., & Zaret, K. S. (2015) · Cell · doi:10.1016/j.cell.2015.03.017 · Cited by 780
“, 2012), focusing on the LIN28B locus that is important for reprogramming and pluripotency (Shyh-Chang et al., 2013; Yu et al., 2007).”
Risk factors in the development of stem cell therapy
Herberts, C. A., Kwa, M. S., & Hermsen, H. P. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-29 · Cited by 753
“The transformation of an adult somatic cell into a pluripotent stem cell (iPSC) was firstly achieved by inducing a “forced” expression of specific genes [8-14].”
BackgroundHuman iPSC-based modeling of late-onset disease via progerin-induced aging
Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., Mandal, P. K., Vera, E., Shim, J.-W., Kriks, S., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.006 · Cited by 777
RNA-Binding Proteins in Cancer: Old Players and New Actors
Pereira, B., Billaud, M., & Almeida, R. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.05.003 · Cited by 773
“For instance, LIN28 is one of the four factors that are sufficient to reprogram human somatic cells into induced pluripotent stem cells [196].”
BackgroundA decade of progress in tissue engineering
Khademhosseini, A., & Langer, R. (2016) · Nature Protocols · doi:10.1038/nprot.2016.123 · Cited by 747
Okita, K., Yamakawa, T., Matsumura, Y., Sato, Y., Amano, N., Watanabe, A., Goshima, N., & Yamanaka, S. (2013) · Stem Cells · doi:10.1002/stem.1293 · Cited by 749
Identification and classification of chromosomal aberrations in human induced pluripotent stem cells
Mayshar, Y., Ben-David, U., Lavon, N., Biancotti, J.-C., Yakir, B., Clark, A. T., Plath, K., Lowry, W. E., & Benvenisty, N. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.07.017 · Cited by 756
“So far, studies describing HiPSCs characterized them at relatively early passage numbers and mainly reported normal karyotypes (Lowry et al., 2008; Park et al., 2008; Takahashi et al., 2007; Yu et al., 2007).”
BackgroundMicroRNAs: key regulators of stem cells
Gangaraju, V. K., & Lin, H. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2621 · Cited by 734
“pl?acc=MI0000001">let-7 family of miRNAs by LIN28 , a developmentally regulated RNA-binding protein that is involved in miRNA processing and promotes the reprogramming of human somatic cells into induced pluripotent stem (iPS) cell”
BackgroundTUT4 in Concert with Lin28 Suppresses MicroRNA Biogenesis through Pre-MicroRNA Uridylation
Heo, I., Joo, C., Kim, Y.-K., Ha, M., Yoon, M.-J., Cho, J., Yeom, K.-H., Han, J., & Kim, V. N. (2009) · Cell · doi:10.1016/j.cell.2009.08.002 · Cited by 798
“It has also been shown that Lin28a overexpression facilitates the formation of inducible pluripotent stem (iPS) cells (Yu et al., 2007).”
BackgroundMummery, C. L., Zhang, J., Ng, E. S., Elliott, D. A., Elefanty, A. G., & Kamp, T. J. (2012) · Circulation Research · doi:10.1161/circresaha.110.227512 · Cited by 713
“line used; and (4) the time of EB plating to allow substrate attachment and outgrowth.”
Direct conversion of human fibroblasts to dopaminergic neurons
Pfisterer, U., Kirkeby, A., Torper, O., Wood, J., Nelander, J., Dufour, A., Björklund, A., Lindvall, O., Jakobsson, J., & Parmar, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105135108 · Cited by 744
Soldner, F., Laganière, J., Cheng, A. W., Hockemeyer, D., Gao, Q., Alagappan, R., Khurana, V., Golbe, L. I., Myers, R. H., Lindquist, S., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.019 · Cited by 728
MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death
Schickel, R., Boyerinas, B., Park, S.-M., & Peter, M. E. (2008) · Oncogene · doi:10.1038/onc.2008.274 · Cited by 719
“In addition, an expression analysis of 217 Oncogene Table 1 miRNAs with relevance in cancer and cell death miRNA Normal function Cancer relevance Cell death relevance Targets References Let-7/miR-98 Upregulated late during Caenorhabditis elegans development; increased expression in differentiated cells; may act to mai…”
BackgroundInfluentialPluripotency and Cellular Reprogramming: Facts, Hypotheses, Unresolved Issues
Hanna, J. H., Saha, K., & Jaenisch, R. (2010) · Cell · doi:10.1016/j.cell.2010.10.008 · Cited by 698
“Reprogramming can be induced not only by Oct4, Sox2, Klf4, and c-Myc but also by alternative combinations that employ Nanog, Lin28, ESRRB, NR5A2, and other genes that promote the establishment of the core transcriptional circuitry of stem cells (Ichida et al., 2009; Yu et al., 2007).”
Generation of transgenic non-human primates with germline transmission
Sasaki, E., Suemizu, H., Shimada, A., Hanazawa, K., Oiwa, R., Kamioka, M., Tomioka, I., Sotomaru, Y., Hirakawa, R., Eto, T., et al. (2009) · Nature · doi:10.1038/nature08090 · Cited by 712
Opposing microRNA families regulate self-renewal in mouse embryonic stem cells
Melton, C., Judson, R. L., & Blelloch, R. (2010) · Nature · doi:10.1038/nature08725 · Cited by 696
Direct reprogramming of human neural stem cells by OCT4
Kim, J. B., Greber, B., Araúzo-Bravo, M. J., Meyer, J., Park, K. I., Zaehres, H., & Schöler, H. R. (2009) · Nature · doi:10.1038/nature08436 · Cited by 577
Direct conversion of human fibroblasts to multilineage blood progenitors
Szabo, E., Rampalli, S., Risueño, R. M., Schnerch, A., Mitchell, R., Fiebig-Comyn, A., Levadoux-Martin, M., & Bhatia, M. (2010) · Nature · doi:10.1038/nature09591 · Cited by 694
Lin-28 interaction with the Let-7 precursor loop mediates regulated microRNA processing
Newman, M. A., Thomson, J. M., & Hammond, S. M. (2008) · RNA · doi:10.1261/rna.1155108 · Cited by 692
“However, a combination of Lin-28, Nanog, Oct-3/4, and Sox2 are sufficient to reprogram human somatic cells to pluripotent stem cells (Yu et al. 2007).”
BackgroundSelf-citationEpigenetic reprogramming in cancer
Suvà, M. L., Riggi, N., & Bernstein, B. E. (2013) · Science · doi:10.1126/science.1230184 · Cited by 706
Reprogramming towards pluripotency requires AID-dependent DNA demethylation
Bhutani, N., Brady, J. J., Damian, M., Sacco, A., Corbel, S. Y., & Blau, H. M. (2010) · Nature · doi:10.1038/nature08752 · Cited by 676
Induced pluripotent stem cells in disease modelling and drug discovery
Rowe, R. G., & Daley, G. Q. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0100-z · Cited by 670
Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells
Raya, Á., Rodríguez-Pizà, I., Guenechea, G., Vassena, R., Navarro, S., Barrero, M. J., Consiglio, A., Castellà, M., Río, P., Sleep, E., et al. (2009) · Nature · doi:10.1038/nature08129 · Cited by 696
Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy
Sun, N., Yazawa, M., Liu, J., Han, L., Sanchez-Freire, V., Abilez, O. J., Navarrete, E. G., Hu, S., Wang, L., Lee, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003552 · Cited by 696
The role of let-7 in cell differentiation and cancer
Boyerinas, B., Park, S.-M., Hau, A., Murmann, A. E., & Peter, M. E. (2010) · Endocrine-Related Cancer · doi:10.1677/erc-09-0184 · Cited by 669
Kim, J., Woo, A. J., Chu, J., Snow, J. W., Fujiwara, Y., Kim, C. G., Cantor, A. B., & Orkin, S. H. (2010) · Cell · doi:10.1016/j.cell.2010.09.010 · Cited by 669
“between Embryonic Stem and Cancer”
A Combined Chemical and Genetic Approach for the Generation of Induced Pluripotent Stem Cells
Shi, Y., Tae Do, J., Desponts, C., Hahm, H. S., Schöler, H. R., & Ding, S. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.05.011 · Cited by 671
“…iPS cells from fibroblasts have shown that, although exogenous expression of Klf4 and c-Myc can be replaced with Nanog 526 Cell Stem Cell 2, June 2008 ª2008 Elsevier Inc. and Lin28 (Yu et al., 2007), expression of Oct3/4 and Sox2 seems to be required based on all iPS cell studies published so far.”
Bacakova, L., Zarubova, J., Travnickova, M., Musilkova, J., Pajorova, J., Slepicka, P., Kasalkova, N. S., Svorcik, V., Kolska, Z., Motarjemi, H., et al. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.03.011 · Cited by 647
Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome
Yazawa, M., Hsueh, B., Jia, X., Pasca, A. M., Bernstein, J. A., Hallmayer, J., & Dolmetsch, R. E. (2011) · Nature · doi:10.1038/nature09855 · Cited by 677
“We next reprogrammed the fibroblasts to generate iPSCs using four retroviruses containing SOX2, OCT3/4, KLF4 and C-MYC 20 , 21 .”
Chen, L.-L., & Carmichael, G. G. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.06.027 · Cited by 659
“This protein also is one of four that together can reprogram somatic cells to pluripotent stem cells (Yu et al., 2007).”
Induced Pluripotent Stem Cell Generation Using a Single Lentiviral Stem Cell Cassette
Sommer, C. A., Stadtfeld, M., Murphy, G. J., Hochedlinger, K., Kotton, D. N., & Mostoslavsky, G. (2009) · Stem Cells · doi:10.1634/stemcells.2008-1075 · Cited by 676
Energy Metabolism in Human Pluripotent Stem Cells and Their Differentiated Counterparts
Varum, S., Rodrigues, A. S., Moura, M. B., Momcilovic, O., Easley, C. A., Ramalho-Santos, J., Van Houten, B., & Schatten, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020914 · Cited by 671
“the ectopic expression of a combination of pluripotency factors and using a variety of approaches [1,2,3].”
BackgroundReprogramming of Human Primary Somatic Cells by OCT4 and Chemical Compounds
Zhu, S., Li, W., Zhou, H., Wei, W., Ambasudhan, R., Lin, T., Kim, J., Zhang, K., & Ding, S. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.11.015 · Cited by 597
“…somatic cells into pluripotent cells that closely resemble embryonic stem cells (ESCs) by introduction of defined transcription factors (TFs), holds great potential in biomedical research and regenerative medicine (Takahashi and Yamanaka, 2006; Takahashi et al., 2007; Yu et al., 2007).”
BackgroundBurridge, P. W., Keller, G., Gold, J. D., & Wu, J. C. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2011.12.013 · Cited by 670
“Finally, definitive proof of this methodology lies in reprogramming skin fibroblasts (and various other cell types) into cardiac cells, as can be done reproducibly for the reprogramming of various adult somatic cell types to pluripotency (Yu et al., 2007; Takahashi et al., 2007).”
Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
Sareen, D., O’Rourke, J. G., Meera, P., Muhammad, A. K. M. G., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007529 · Cited by 670
“Three independent iPSCcloneswill be picked fromeach reprogrammed fibroblast sample, further expanded, and cryopreserved according to previously published protocols (48).”
MethodGrowth of engineered human myocardium with mechanical loading and vascular coculture
Tulloch, N. L., Muskheli, V., Razumova, M. V., Korte, F. S., Regnier, M., Hauch, K. D., Pabon, L., Reinecke, H., & Murry, C. E. (2011) · Circulation Research · doi:10.1161/circresaha.110.237206 · Cited by 666
“Furthermore, these optimized human cardiac tissue constructs (4) can be generated from human iPSC-derived cells and (5) can generate active forces responsive to changes in construct length, analogous to Starling curves generated in the intact heart.”
Role of the Murine Reprogramming Factors in the Induction of Pluripotency
Sridharan, R., Tchieu, J., Mason, M. J., Yachechko, R., Kuoy, E., Horvath, S., Zhou, Q., & Plath, K. (2009) · Cell · doi:10.1016/j.cell.2009.01.001 · Cited by 643
“Reprogramming of human and mouse fibroblasts to induced pluripotent stem (iPS) cells has been achieved by the expression of only four transcription factors, Oct4, Sox2, Klf4, and c-Myc, subsequently referred to as the ‘‘four factors’’ (Maherali et al., 2007; Okita et al., 2007; Takahashi et al., 2007; Takahashi and Ya…”
Yamanaka, S. (2009) · Cell · doi:10.1016/j.cell.2009.03.034 · Cited by 659
“In 2007, germline transmission was achieved with mouse iPS cells (Meissner et al., 2007; Okita et al., 2007; Wernig et al., 2007), and iPS cells were generated from human fibroblasts (Park et al., 2008b; Takahashi et al., 2007; Yu et al., 2007).”
BackgroundBiomimetic nanofibrous scaffolds for bone tissue engineering
Holzwarth, J. M., & Ma, P. X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.09.009 · Cited by 654
“In order to circumvent that, induced pluripotent stem cells (iPSCs) were developed [71,72] to provide a pluripotent stem cell line that avoided the controversy surrounding human ESCs.”
Cell-laden hydrogels for osteochondral and cartilage tissue engineering
Yang, J., Zhang, Y. S., Yue, K., & Khademhosseini, A. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.01.036 · Cited by 652
Müller glial cell reprogramming and retina regeneration
Goldman, D. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3723 · Cited by 625
Chiou, S.-H., Yu, C.-C., Huang, C.-Y., Lin, S.-C., Liu, C.-J., Tsai, T.-H., Chou, S.-H., Chien, C.-S., Ku, H.-H., & Lo, J.-F. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4404 · Cited by 641
Chromatin-modifying enzymes as modulators of reprogramming
Onder, T. T., Kara, N., Cherry, A., Sinha, A. U., Zhu, N., Bernt, K. M., Cahan, P., Mancarci, B. O., Unternaehrer, J., Gupta, P. B., et al. (2012) · Nature · doi:10.1038/nature10953 · Cited by 634
Stem Cells Applications in Regenerative Medicine and Disease Therapeutics
Mahla, R. S. (2016) · International Journal of Cell Biology · doi:10.1155/2016/6940283 · Cited by 604
“Ectopic expression or functional restoration of endogenous pluripotency factors epigenetically transforms terminally differentiated cells into ESCs-like cells [3], known as induced pluripotent stem cells (iPSCs) [3, 4].”
BackgroundTargeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells
Yusa, K., Rashid, S. T., Strick-Marchand, H., Varela, I., Liu, P.-Q., Paschon, D. E., Miranda, E., Ordóñez, A., Hannan, N. R. F., Rouhani, F. J., et al. (2011) · Nature · doi:10.1038/nature10424 · Cited by 639
Mechanisms of Stem Cell Self-Renewal
Shenghui, H., Nakada, D., & Morrison, S. J. (2009) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.042308.113248 · Cited by 603
“…combinations of other transcription factors including Sox2 and Nanog can reprogram differentiated mouse and human cells into ES-like induced pluripotent stem (iPS) cells (Okita et al. 2007, Park et al. 2008, Takahashi et al. 2007, Takahashi & Yamanaka 2006, Wernig et al. 2007, Yu et al. 2007).”
BackgroundGeneration of vascular endothelial and smooth muscle cells from human pluripotent stem cells
Patsch, C., Challet-Meylan, L., Thoma, E. C., Urich, E., Heckel, T., O’Sullivan, J. F., Grainger, S. J., Kapp, F. G., Sun, L., Christensen, K., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3205 · Cited by 629
Senescence impairs successful reprogramming to pluripotent stem cells
Banito, A., Rashid, S. T., Acosta, J. C., Li, S., Pereira, C. F., Geti, I., Pinho, S., Silva, J. C., Azuara, V., Walsh, M., et al. (2009) · Genes & Development · doi:10.1101/gad.1811609 · Cited by 642
“The generation of iPS cells from human cells was achieved a year later by two research groups (Takahashi et al., 2007; Yu et al., 2007).”
BackgroundInfluentialBar-Nur, O., Russ, H. A., Efrat, S., & Benvenisty, N. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2011.06.007 · Cited by 611
“Human induced pluripotent stem cells (HiPSCs) have been generated from human somatic fibroblasts (Lowry et al., 2008; Park et al., 2008; Takahashi et al., 2007; Yu et al., 2007) and other human cell types, including CD34 cells from peripheral blood (Loh et al.”
Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon
Yusa, K., Rad, R., Takeda, J., & Bradley, A. (2009) · Nature Methods · doi:10.1038/nmeth.1323 · Cited by 620
“1b). cMyc from the 4-factor vector and Lin28 from the 5-factor vector were detected migrating at the same molecular weights as their endogenous counterparts.”
InfluentialLin28A and Lin28B Inhibit let-7 MicroRNA Biogenesis by Distinct Mechanisms
Piskounova, E., Polytarchou, C., Thornton, J. E., LaPierre, R. J., Pothoulakis, C., Hagan, J. P., Iliopoulos, D., & Gregory, R. I. (2011) · Cell · doi:10.1016/j.cell.2011.10.039 · Cited by 612
“Restoration of let-7 expression effectively inhibits cancer growth in mouse models of lung and breast cancers (Barh et al., 2010; Esquela-Kerscher et al., 2008; Slack, 2009; Trang et al., 2010; Yu et al., 2007a).”
Ban, H., Nishishita, N., Fusaki, N., Tabata, T., Saeki, K., Shikamura, M., Takada, N., Inoue, M., Hasegawa, M., Kawamata, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103509108 · Cited by 605
“S and more efficient reprogramming methods have been explored since the first report of the generation of human induced pluripotent stem cells (iPSCs) (1, 2).”
BackgroundParkinson's disease: Mechanisms, translational models and management strategies
Raza, C., Anjum, R., & Shakeel, N. U. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.057 · Cited by 603
Generation of induced pluripotent stem cells from human blood
Loh, Y.-H., Agarwal, S., Park, I.-H., Urbach, A., Huo, H., Heffner, G. C., Kim, K., Miller, J. D., Ng, K., & Daley, G. Q. (2009) · Blood · doi:10.1182/blood-2009-02-204800 · Cited by 626
Lian, Q., Zhang, Y., Zhang, J., Zhang, H. K., Wu, X., Zhang, Y., Lam, F. F.-Y., Kang, S., Xia, J. C., Lai, W.-H., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.898312 · Cited by 618
Dynamic stem cell states: Naive to primed pluripotency in rodents and humans
Weinberger, L., Ayyash, M., Novershtern, N., & Hanna, J. H. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.28 · Cited by 622
Organoids: A historical perspective of thinking in three dimensions
Simian, M., & Bissell, M. J. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201610056 · Cited by 620
“Induced pluripotent stem cells, a breakthrough that took place in 2007, have provided an additional tool to study morphogenesis (Takahashi et al., 2007; Yu et al., 2007; Park et al., 2008).”
Backgroundlet-7 microRNAs in development, stem cells and cancer
Büssing, I., Slack, F. J., & Großhans, H. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.07.001 · Cited by 607
Generation of human induced pluripotent stem cells from urine samples
Zhou, T., Benda, C., Dunzinger, S., Huang, Y., Ho, J. C., Yang, J., Wang, Y., Zhang, Y., Zhuang, Q., Li, Y., et al. (2012) · Nature Protocols · doi:10.1038/nprot.2012.115 · Cited by 614
Modeling early retinal development with human embryonic and induced pluripotent stem cells
Meyer, J. S., Shearer, R. L., Capowski, E. E., Wright, L. S., Wallace, K. A., McMillan, E. L., Zhang, S.-C., & Gamm, D. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905245106 · Cited by 601
“(11) showed that human iPS cell lines differed in their early expression of Pax6, a finding confirmed here.”
BackgroundResultPioneer transcription factors in cell reprogramming
Iwafuchi-Doi, M., & Zaret, K. S. (2014) · Genes & Development · doi:10.1101/gad.253443.114 · Cited by 597
“That the Pou5f3 and Sox2 factors can serve a pioneering function during zygotic genome activation (see above) underscores the special abilities of these factors.”
BackgroundInfluentialPrigione, A., Fauler, B., Lurz, R., Lehrach, H., & Adjaye, J. (2010) · Stem Cells · doi:10.1002/stem.404 · Cited by 598
Stem cell metabolism in tissue development and aging
Shyh-Chang, N., Daley, G. Q., & Cantley, L. C. (2013) · Development · doi:10.1242/dev.091777 · Cited by 574
“In mammals, LIN28A/B have been found to be regulators of pluripotent ESCs and iPSCs, fetal HSCs, neural crest progenitors, skeletal myoblasts during muscle regeneration and spermatogonia (Viswanathan et al., 2008; Yu et al., 2007; Yuan et al., 2012; Molenaar et al., 2012; Polesskaya et al., 2007; Zheng et al., 2009).”
BackgroundModeling familial Alzheimer's disease with induced pluripotent stem cells
Yagi, T., Ito, D., Okada, Y., Akamatsu, W., Nihei, Y., Yoshizaki, T., Yamanaka, S., Okano, H., & Suzuki, N. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr394 · Cited by 599
“Generation of human iPSCs provides a new method for elucidating the molecular basis of human disease (14,15).”
MethodOpen chromatin in pluripotency and reprogramming
Gaspar-Maia, A., Alajem, A., Meshorer, E., & Ramalho-Santos, M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3036 · Cited by 573
A chemical platform for improved induction of human iPSCs
Lin, T., Ambasudhan, R., Yuan, X., Li, W., Hilcove, S., Abujarour, R., Lin, X., Hahm, H. S., Hao, E., Hayek, A., et al. (2009) · Nature Methods · doi:10.1038/nmeth.1393 · Cited by 596
Pluripotent stem cells in disease modelling and drug discovery
Avior, Y., Sagi, I., & Benvenisty, N. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2015.27 · Cited by 592
Zhang, D., Jiang, W., Liu, M., Sui, X., Yin, X., Chen, S., Shi, Y., & Deng, H. (2009) · Cell Research · doi:10.1038/cr.2009.28 · Cited by 581
Chiou, S.-H., Wang, M.-L., Chou, Y.-T., Chen, C.-J., Hong, C.-F., Hsieh, W.-J., Chang, H.-T., Chen, Y.-S., Lin, T.-W., Hsu, H.-S., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2638 · Cited by 575
Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome
Paşca, S. P., Portmann, T., Voineagu, I., Yazawa, M., Shcheglovitov, A., Paşca, A. M., Cord, B., Palmer, T. D., Chikahisa, S., Nishino, S., et al. (2011) · Nature Medicine · doi:10.1038/nm.2576 · Cited by 585
Seki, T., Yuasa, S., Oda, M., Egashira, T., Yae, K., Kusumoto, D., Nakata, H., Tohyama, S., Hashimoto, H., Kodaira, M., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.003 · Cited by 584
“Initially, human dermal fibroblasts were used to derive human iPSCs (hiPSCs) (Takahashi et al., 2007; Yu et al., 2007).”
BackgroundGeneration of pluripotent stem cells from patients with type 1 diabetes
Maehr, R., Chen, S., Snitow, M., Ludwig, T., Yagasaki, L., Goland, R., Leibel, R. L., & Melton, D. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906894106 · Cited by 568
Opportunities and challenges of translational 3D bioprinting
Murphy, S. V., De Coppi, P., & Atala, A. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0471-7 · Cited by 563
Li, W., Wei, W., Zhu, S., Zhu, J., Shi, Y., Lin, T., Hao, E., Hayek, A., Deng, H., & Ding, S. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2008.11.014 · Cited by 567
“…and efficiency (Figure 2A, 15 20 iPSC colonies from 1 3 105 transduced cells on average) as has been reported using conventional hESC conditions (Yu et al., 2007), and these colonies could be subsequently selected/stabilized and further expanded with the addition of the chemical cocktail of…”
Epigenetic reprogramming and induced pluripotency
Hochedlinger, K., & Plath, K. (2009) · Development · doi:10.1242/dev.020867 · Cited by 553
“Moreover, human fibroblasts (Lowry et al., 2008; Park et al., 2008b; Takahashi et al., 2007) and keratinocytes (Aasen et al., 2008; Maherali et al., 2008) have been converted into iPS cells using the same, and also using a different combination of factors, including OCT4, SOX2, LIN28 and NANOG (Yu et al., 2007).”
BackgroundInfluentialWang, Y. I., Abaci, H. E., & Shuler, M. L. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26045 · Cited by 563
“Human iPSCs IMR90-4 (WiCell, Madison, WI; Yu et al., 2007) were maintained and differentiated to brain microvascular endothelial cells (BMECs) based on the protocol developed by Lippmann et al. (2014).”
MethodSánchez‐Danés, A., Richaud‐Patin, Y., Carballo‐Carbajal, I., Jiménez‐Delgado, S., Caig, C., Mora, S., Di Guglielmo, C., Ezquerra, M., Patel, B., Giralt, A., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201200215 · Cited by 560
“The advent of induced pluripotent stem cell (iPSC) technology (Takahashi & Yamanaka, 2006) has made it possible to reprogram human somatic cells to pluripotency (Park et al, 2008b; Takahashi et al, 2007; Yu et al, 2007), thus enabling the generation of disease-specific iPSC (Lee & Studer, 2010).”
Rejuvenating senescent and centenarian human cells by reprogramming through the pluripotent state
Lapasset, L., Milhavet, O., Prieur, A., Besnard, E., Babled, A., Aït-Hamou, N., Leschik, J., Pellestor, F., Ramirez, J.-M., De Vos, J., et al. (2011) · Genes & Development · doi:10.1101/gad.173922.111 · Cited by 570
“2007) transcription factor cocktail (OSKM) or by an alternative combination of four factors (OSNL), substituting KLF4 and c-MYC with NANOG and LIN28 (Yu et al. 2007).”
BackgroundMethodInfluentialBershteyn, M., Nowakowski, T. J., Pollen, A. A., Di Lullo, E., Nene, A., Wynshaw-Boris, A., & Kriegstein, A. R. (2017) · Cell Stem Cell · doi:10.1016/j.stem.2016.12.007 · Cited by 566
“To bridge the gap between mouse models and human disease, patient-derived induced pluripotent stem cells (iPSCs) (Takahashi et al., 2007; Yu et al., 2007; Park et al., 2008) represent a promising approach to study disease pathogenesis in a relevant genetic and cellular context.”
BackgroundDistinct Lineage Specification Roles for NANOG, OCT4, and SOX2 in Human Embryonic Stem Cells
Wang, Z., Oron, E., Nelson, B., Razis, S., & Ivanova, N. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.02.016 · Cited by 554
“Given the key roles of Nanog, Oct4, and Sox2 in mESCs and their ability to induce pluripotency in human somatic cells (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007), it has been assumed that these genes have important and conserved functions in hESCs.”
BackgroundRegulation of Spermatogonial Stem Cell Self-Renewal in Mammals
Oatley, J. M., & Brinster, R. L. (2008) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.24.110707.175355 · Cited by 550
“Recently, several reports have described the conversion of adult somatic cells into pluripotent ES cell–like cells in vitro, referred to as induced pluripotent stem (iPS) cells (Takahashi & Yamanaka 2006, Takahashi et al. 2007, Wernig et al. 2007, Yu et al. 2007).”
BackgroundResultA High-Efficiency System for the Generation and Study of Human Induced Pluripotent Stem Cells
Maherali, N., Ahfeldt, T., Rigamonti, A., Utikal, J., Cowan, C., & Hochedlinger, K. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.08.003 · Cited by 563
“While human fibroblasts and a multitude of mouse somatic cell types can be reprogrammed to pluripotency by ectopic expression of transcription factors (Takahashi and Yamanaka, 2006; Maherali et al., 2007; Okita et al., 2007; Wernig et al., 2007; Takahashi et al., 2007; Yu et al., 2007; Lowry et al., 2008; Aoi et al.,…”
Corrò, C., Novellasdemunt, L., & Li, V. S. W. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00120.2020 · Cited by 561
Engineered In Vitro Disease Models
Benam, K. H., Dauth, S., Hassell, B., Herland, A., Jain, A., Jang, K.-J., Karalis, K., Kim, H. J., MacQueen, L., Mahmoodian, R., et al. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040418 · Cited by 554
“Human iPSCs, which are derived from somatic cells by overexpression of a few transcription factors (3, 4), can be generated from patients with or without a specific disease, and the resulting pluripotent cells can self-renew indefinitely.”
BackgroundRing, K. L., Tong, L. M., Balestra, M. E., Javier, R., Andrews-Zwilling, Y., Li, G., Walker, D., Zhang, W. R., Kreitzer, A. C., & Huang, Y. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.018 · Cited by 538
“After seminal studies that succeeded in reprogramming mouse and human somatic cells to iPSCs (Takahashi et al., 2007; Takahashi and Yamanaka, 2006; Yu et al., 2007), researchers have taken great strides to improve reprogramming methods and to apply the technology to the understanding and potential future treatment of…”
Metadata
- Authors
- Yu, J., Vodyanik, M. A., Smuga-Otto, K., Antosiewicz-Bourget, J., Frane, J. L., Tian, S., Nie, J., Jonsdottir, G. A., Ruotti, V., Stewart, R., Slukvin, I. I., & Thomson, J. A.
- Affiliations
- WiCell (US)
- Genome Center of Wisconsin, Madison, WI 53706–1580, USA.
- Venue
- Science
- Published
- 2007-12-21
- Volume
- 318
- Issue
- 5858
- Pages
- 1917-1920
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2142046859
- Cited by
- 10,310
- References
- 14
- Citations by year
- 2026: 167 · 2025: 219 · 2024: 285 · 2023: 322 · 2022: 332 · 2021: 506 · 2020: 441 · 2019: 443 · 2018: 452 · 2017: 515 · 2016: 580 · 2015: 652 · 2014: 692 · 2013: 816 · 2012: 940
- FWCI
- 271.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (P20GM069981)
- National Center for Research Resources (P51RR000167)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- induced pluripotent stem cells, somatic cell nuclear transfer, reprogramming factors, Oct4, SOX2, Nanog, Lin28, pluripotency, telomerase activity, germ layer differentiation, karyotype, disease models, drug development, transplantation medicine
- MeSH terms
- Nanog Homeobox Protein, Animals, Cell Differentiation, Cell Line, DNA-Binding Proteins, Fetus, Fibroblasts, Humans, Infant, Newborn, Karyotyping, Teratoma, Transcription Factors, Transduction, Genetic, Mice, SCID, RNA-Binding Proteins, Homeodomain Proteins, Transgenes, Oligonucleotide Array Sequence Analysis, HMGB Proteins, Stem Cell Transplantation, Pluripotent Stem Cells, Cell Shape, Cell Proliferation, Octamer Transcription Factor-3, Mice, Embryonic Stem Cells, SOXB1 Transcription Factors, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.